Value of Power Doppler and 3D vascular sonography as a method for diagnosis and staging of prostate cancer

European Urology

Volumn 44, Issue 1, 2003, Pages 21-31

  Sauvain, J L ^a   Palascak, P ^b   Bourscheid, D ^b   Chabi, C ^b   Atassi, A ^b   Bremon, J M ^a   Palascak, R ^b  

^a Medical Imaging Center   (France)

^b Paul Morel Hospital   (France)

Author keywords

Prostate biopsy; Prostate cancer; Prostate Doppler

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DOPPLER FLOWMETRY; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION;

EID: 0037636338     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(03)00204-5     Document Type: Article

References (36)

1. Neal DE, Donovan JL. Prostate cancer: to screen or not to screen? Lancet Oncol 2000;1(1):17-24.
2. Masai M, Ito H, Kotake T, Nagao K. Serum prostate specific antigen and prostate specific antigen density in patients receiving radical prostatectomy. Int J Urol 1996;3:118-23.
3. Stamey TA, Yang N, Hay AR, McNeal JE. Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl J Med 1987;317:909-16.
4. Bostwick DG. Staging Prostate cancer-1997: Current Methods and limitation. Eur Urol 1997;32:2-14.
5. Littrup P, Sparschu R. Transrectal ultrasound and prostate cancer risks: the tailored prostate biopsy. Cancer 1995;75(Suppl):1805-13.
6. Resnick NI, Willard JW, Boyce WH. Ultrasonic evaluation of the prostatic nodule. J Urol 1981;120:86-9.
7. Rifkin M, Sudakoff G, Alexander A. Prostate: techniques, results and potential applications of color Doppler US scanning. Radiology 1993;186:509-13.
8. Aarnink RG, Beerlage HP, de la Rosette JJ, Debruyne FM, Wijkstra. Transrectal ultrasound of the prostate: innovations and future applications. J Urol 1998;159:1568-79.
9. Brendler CB. Characteristics of prostate cancer found with early detection regimens. Urology 1995;46(3 Suppl A):71-6.
10. Kelly I, Lees W, Rickards D. Prostate cancer and the role of color Doppler US. Radiology 1993;189:153-6.
11. Newmann JS, Bree RL, Rubin JM. Prostate cancer: diagnosis with color Doppler sonography with histological correlation of each biopsy site. Radiology 1995;195(1):86-90.
12. Bree RL. The role of color Doppler and staging biopsies in prostate cancer detection. Urology 1997;49:31-4.
13. Lavoipierre AM, Snow RM, Frydenberg M, Gunter D, Reisner G, Royce PL, et al. Prostatic cancer: role of color Doppler imaging in transrectal sonography. Am J Roentgenol 1998;171(1):205-10.
14. Cornud F, Hamida K, Flam T, Helenon O, Chretien Y, Thiounn N, et al. Endorectal color Doppler Sonography and endorectal MR, imaging feature of non palpable prostate cancer: correlation with radical prostatectomy findings. Am J Roentgenol 2000;175:1161-8.
15. Halpern EJ, Strup SE. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. Am J Roentgenol 2000;174:623-7.
16. Sauvain JL, Palascak P, Bremon JM. Power Doppler ultrasonography and hypoechoic nodules of peripheral prostate: prospective and limitations. J Radiol 1997;78:491-7.
17. Sauvain JL, Palascak P, Bourscheid D, Bloqueau P, Bremon JM, Jung L, et al. Power Doppler and 3D vascular sonography of intra prostatic blood supply: assessment criteria and value for diagnosis and staging of prostate cancer. Prog Urol 2000;10:237-45.
18. Leventis AK, Shariat SF, Utsunomiya T, Slavim KT. Characteristics of normal prostate vascular anatomy as displayed by power Doppler. Prostate 2001;46(4):281-8.
19. Rubin JM, Budc RO, Carson PL, Bree RL, Adler RS. Power Doppler US: a potential useful alternative to mean frequency based color Doppler US. Radiology 1994;190:853-6.
20. Sedelar JP, Van Leenders GL, Hulsbergen-van De Kaa CA, Van Der Poel HG, Van Der Laak JA, Debruyne FM, et al. Microvessels density: correlation between contrast ultrasonography and histology of prostate cancer. Eur Urol 2001;40(3):285-93.
21. Brawer MK, Beatie J, Wener MH, Vessella RL, Preston SD, Lange PH. Screening for prostatic carcinoma with prostate specific antigen: results of the second year. J Urol 1993;150:106-9.
22. Epstein JL, Carmichael MJ, Pizov G, Walsh PC. Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long term follow up. J Urol 1993;150:135-41.
23. Rosen MA, Goldstone L, Lapin S, Wheeler T, Scardino PT. Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimen. J Urol 1992;148:331-7.
24. Furosato K, Walkui S, Sasaki H. Tumor angiogenesis in latent prostatic carcinoma. Br J of Cancer 1994;70:1244-6.
25. Brawer MK, Deering RE, Brown M. Predictors of pathologic stage in prostatic carcinoma: the role of neovascularity. Cancer 1994;73:678-87.
26. Weidner N, Caroll PR, Flax J, Folkmann J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Sug Pathol 143:401-9.
27. Cornud F, Belin X, Piron D, Chretien Y, Flam T, Casanova JM, et al. Color Doppler guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for non palpable lesions. Urology 1997;49(5):709-15.
28. Frauscher F, Klauser A, Volgger H, Halpern EJ, Pallwein L, Steiner H, et al. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 2002;167(4):1645-8.
29. Boccon-Gibod L. Rising PSA with a negative biopsy. Eur Urol 2001;40(2):3-8.
30. Djavan B, Remzi M, Schulmann CC, Marberger M, Zlotta AR. Repeat prostate biopsy: who, how and when? A review. Eur Urol 2002;42(2):93-103.
31. Niemann TH, Bahnson RR. Extended sector biopsy for detection of carcinoma of the prostate. Urol Oncol 2001;6(3):91-3.
32. Gohji K, Morisue K, Kizaki T, Fujii A. Correlation of transrectal ultrasound imaging and the results of systematic biopsy with pathological examination of radical prostatectomy specimens. Br J Urol 1995;75:758-65.
33. Ismail M, Petersen RO, Alexander AA, Newschaffer C, Gomella LG. Color Doppler Imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival. Urology 1997;50(6):906-12.
34. Shinohara K, Wheeler T, Scardino PT. The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations. J Urol 1989;142:76-82.
35. Ayala AG, Ro JY, Babaian R, Troncoso P, Grignon DJ. The prostatic capsule: does it exist? Its importance in the staging and treatment of prostatic carcinoma. Am J Surg Pathol 1989;13:21-7.
36. Young MP, Jones DR, Grifiths GJ, Peeling WB, Roberts EE, Parkinson MC. Prostatic capsule: a comparative study of histological and ultrasonic appearances. Eur Urol 1993;24:479-82.